Early menopause and your long-term health
The earlier menopause happens, the more years your body spends without estrogen — and that longer span is what drives the health risks that come with it.
Premature menopause Age 45
Early menopause Age 51
Average menopause
The shaded span is the extra time your body goes without estrogen compared to the average — sometimes a decade or more.
Here's what's actually happening
The average age of menopause is around 51. When menopause happens before age 45, it is called early menopause; before age 40, it is called premature menopause or primary ovarian insufficiency. Both shift the timeline of your life so that you are without estrogen for more years than most women — and that extended gap is the central reason your long-term health risks are higher.
Estrogen does more than regulate periods. It supports the lining of your blood vessels, the strength of your bones, and the structure and function of your brain. When estrogen falls early, those protections fall away earlier too. Early menopause is not a problem of one year — it is a problem of the many years your body was not supposed to be without estrogen yet.
What the long-term risks actually are
Three areas of health are most affected by early menopause: the heart and blood vessels, the bones, and the brain. Each is shaped by estrogen, and each feels the loss when estrogen is gone too soon.
Estrogen keeps blood vessels flexible and supports favorable cholesterol patterns. When estrogen is lost early, cholesterol tends to rise, blood pressure can climb, and body fat tends to shift in ways that raise cardiovascular risk.
30–60% higher risk of heart disease & strokeEstrogen is one of the most important signals telling your bones to maintain themselves. Without it, bone loss accelerates. Bone density lost during the years you should not yet be losing it is the foundation of fracture risk decades later.
Meaningfully higher lifetime risk of osteoporosis & fractureEstrogen affects how brain cells communicate, how blood flows through the brain, and how the brain manages inflammation and energy. Early menopause is associated with higher rates of memory difficulty and dementia, including Alzheimer's disease.
Starting HT at the time of early menopause may lower this riskWhat this means for your care
For women with early menopause, the standard of care is hormone therapy continued until at least the average age of menopause — about 50 to 51 — to replace what your body is missing during the years it should not yet be missing it. The goal is not only symptom management but also preventing the long-term consequences of years of unintended estrogen deficiency.
- Hormone therapy continued through the years your body should still have estrogen
- Lab work to confirm your estradiol level is actually in the range that protects your heart, bones, and brain — per guidelines, therapy is dosed to a target level, not just to symptom relief
- Bone density testing on an appropriate schedule
- Cardiovascular risk assessment, with attention to cholesterol and blood pressure
- An open conversation about any cognitive changes
- Movement, balanced nutrition, no smoking, alcohol within reasonable limits — alongside hormone therapy, not as a substitute for it
"Early menopause changes the timeline, not the destination. With hormone therapy through the years your body should still have estrogen, the long-term risks can be brought much closer to those of women who reach menopause at the usual age."
Research & references
- Mishra GD, Davies MC, Hillman S, et al. Optimising Health After Early Menopause. Lancet. 2024;403(10430):958–968.
- Nash Z, Al-Wattar BH, Davies M. Bone and Heart Health in Menopause. Best Practice & Research. Clinical Obstetrics & Gynaecology. 2022;81:61–68.
- Muka T, Oliver-Williams C, Kunutsor S, et al. Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes. JAMA Cardiology. 2016;1(7):767–776.
- Davis SR, Baber RJ. Treating Menopause — MHT and Beyond. Nature Reviews. Endocrinology. 2022;18(8):490–502.
- Savukoski SM, Niinimäki M. The Long-Term Health Effects of Early Menopause. Seminars in Reproductive Medicine. 2025.
- El Khoudary SR, Aggarwal B, Beckie TM, et al. Menopause Transition and Cardiovascular Disease Risk. Circulation. 2020;142(25):e506–e532.
- Mosconi L, Nerattini M, Williams S, Fink M. New Horizons in Menopause, MHT, and Alzheimer's Disease. Journal of Clinical Endocrinology and Metabolism. 2025;110(4):911–921.
- Sochocka M, Karska J, Pszczołowska M, et al. Cognitive Decline in Early and Premature Menopause. International Journal of Molecular Sciences. 2023;24(7):6566.
- Nerattini M, Jett S, Andy C, et al. Systematic Review and Meta-Analysis of the Effects of Menopause Hormone Therapy on Risk of Alzheimer's Disease and Dementia. Frontiers in Aging Neuroscience. 2023;15:1260427.
- Schwarz KG, Vicencio SC, Inestrosa NC, et al. Autonomic Nervous System Dysfunction Throughout Menopausal Transition. Journal of Physiology. 2023.
- Stuenkel CA, Gompel A. Primary Ovarian Insufficiency. New England Journal of Medicine. 2023;388(2):154–163.
- Crandall CJ, Mehta JM, Manson JE. Management of Menopausal Symptoms: A Review. JAMA. 2023;329(5):405–420.
- Manson JE, Crandall CJ, Rossouw JE, et al. The Women's Health Initiative Randomized Trials and Clinical Practice: A Review. JAMA. 2024;331(20):1748–1760.